organization · Reporting owner
General Atlantic (OSH) Interholdco, L.P.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Oak Street Health, Inc.
Report date May 02, 2023 · Filed May 02, 2023
Jointly reported with GENERAL ATLANTIC, L.P., GENERAL ATLANTIC GENPAR, L.P., General Atlantic Partners 93, L.P., General Atlantic Partners 100, L.P., GAP COINVESTMENTS III, LLC, GAP COINVESTMENTS IV, LLC, GAP Coinvestments V, LLC, GAP Coinvestments CDA, L.P., General Atlantic (SPV) GP, LLC
Section 16 reporting ended · disclosed 2023-05-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.001 per shareSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2023-05-02 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2023-05-02 · Other · Disposed 61,384,475 · Balance 0 F1: On May 2, 2023, CVS Pharmacy, Inc. (?Parent?) acquired Oak Street Health, Inc. (?Oak Street Health? or the "Issuer") pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent, Halo Merger Sub Corp. (?Merger Sub?), a direct wholly owned subsidiary of Parent, and, for the limited purposes set forth therein, CVS Health Corporation, dated as of February 7, 2023 (the ?Merger Agreement?). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the ?Merger?), with the Issuer surviving such merger as a wholly owned subsidiary of Parent. F2: Pursuant to the terms of the Merger Agreement, each outstanding share of common stock, par value $0.001 per share, of the Issuer, issued and outstanding immediately prior to the effective time of the Merger (other than such shares (i) held by Oak Street Health as treasury stock as of immediately prior to the effective time, (ii) owned by Parent or any of its subsidiaries (including Merger Sub) as of immediately prior to the effective time, (iii) owned by stockholders who have properly exercised appraisal rights under Delaware law and (iv) subject to outstanding Oak Street Health restricted stock awards), was automatically cancelled and converted into the right to receive $39.00 per share in cash, without interest. F3: Reflects securities held directly by General Atlantic (OSH) Interholdco, L.P. (?GA Interholdco?) following the closing of the Merger. General Atlantic Partners 93, L.P., a Delaware limited partnership ("GAP 93"), General Atlantic Partners 100, L.P., a Delaware limited partnership ("GAP 100"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), and GAP Coinvestments V, LLC, a Delaware limited liability company (cont?d in FN 4). F4: (cont?d from FN 3) ("GAPCO V" and, together with GAP 93, GAP 100, GAPCO CDA, GAPCO III and GAPCO IV, the "GA Funds") are the limited partners of GA Interholdco. General Atlantic GenPar, L.P. ("GA GenPar") is the general partner of GAP 93 and GAP 100. General Atlantic (SPV) GP, LLC ("GA SPV") is the general partner of GA Interholdco. General Atlantic, L.P. ("GA LP") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. There are nine members of the management committee of GA LP (the "GA Management Committee"). Each of the members of the GA Management Committee disclaims ownership of the shares except to the extent he or she has a pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 2, 2023, CVS Pharmacy, Inc. (?Parent?) acquired Oak Street Health, Inc. (?Oak Street Health? or the "Issuer") pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent, Halo Merger Sub Corp. (?Merger Sub?), a direct wholly owned subsidiary of Parent, and, for the limited purposes set forth therein, CVS Health Corporation, dated as of February 7, 2023 (the ?Merger Agreement?). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the ?Merger?), with the Issuer surviving such merger as a wholly owned subsidiary of Parent.
F2: Pursuant to the terms of the Merger Agreement, each outstanding share of common stock, par value $0.001 per share, of the Issuer, issued and outstanding immediately prior to the effective time of the Merger (other than such shares (i) held by Oak Street Health as treasury stock as of immediately prior to the effective time, (ii) owned by Parent or any of its subsidiaries (including Merger Sub) as of immediately prior to the effective time, (iii) owned by stockholders who have properly exercised appraisal rights under Delaware law and (iv) subject to outstanding Oak Street Health restricted stock awards), was automatically cancelled and converted into the right to receive $39.00 per share in cash, without interest.
F3: Reflects securities held directly by General Atlantic (OSH) Interholdco, L.P. (?GA Interholdco?) following the closing of the Merger. General Atlantic Partners 93, L.P., a Delaware limited partnership ("GAP 93"), General Atlantic Partners 100, L.P., a Delaware limited partnership ("GAP 100"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), and GAP Coinvestments V, LLC, a Delaware limited liability company (cont?d in FN 4).
F4: (cont?d from FN 3) ("GAPCO V" and, together with GAP 93, GAP 100, GAPCO CDA, GAPCO III and GAPCO IV, the "GA Funds") are the limited partners of GA Interholdco. General Atlantic GenPar, L.P. ("GA GenPar") is the general partner of GAP 93 and GAP 100. General Atlantic (SPV) GP, LLC ("GA SPV") is the general partner of GA Interholdco. General Atlantic, L.P. ("GA LP") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. There are nine members of the management committee of GA LP (the "GA Management Committee"). Each of the members of the GA Management Committee disclaims ownership of the shares except to the extent he or she has a pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 02, 2023 Filed May 2, 2023 17:34 UTC | Oak Street Health, Inc. OSH · Entity 113906 | OtherCommon Stock, par value $0.001 per share | 61,384,475 | $39.00 | $2,393,994,525.00 |
DisclosureSEC source: 0000950142-23-001309 · es230355038_4-osh.xml · nonDerivative · entry 1 GENERAL ATLANTIC, L.P. · CIK 0001017645 · Director · 10% owner GENERAL ATLANTIC GENPAR, L.P. · CIK 0001467926 · 10% owner General Atlantic Partners 93, L.P. · CIK 0001567885 · 10% owner General Atlantic Partners 100, L.P. · CIK 0001704892 · 10% owner GAP COINVESTMENTS III, LLC · CIK 0001282203 · 10% owner GAP COINVESTMENTS IV, LLC · CIK 0001282372 · 10% owner GAP Coinvestments V, LLC · CIK 0001793941 · 10% owner GAP Coinvestments CDA, L.P. · CIK 0001356474 · 10% owner General Atlantic (SPV) GP, LLC · CIK 0001793940 · 10% owner General Atlantic (OSH) Interholdco, L.P. · CIK 0001793934 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 F1 · kind: On May 2, 2023, CVS Pharmacy, Inc. (?Parent?) acquired Oak Street Health, Inc. (?Oak Street Health? or the "Issuer") pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent, Halo Merger Sub Corp. (?Merger Sub?), a direct wholly owned subsidiary of Parent, and, for the limited purposes set forth therein, CVS Health Corporation, dated as of February 7, 2023 (the ?Merger Agreement?). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the ?Merger?), with the Issuer surviving such merger as a wholly owned subsidiary of Parent. F2 · price: Pursuant to the terms of the Merger Agreement, each outstanding share of common stock, par value $0.001 per share, of the Issuer, issued and outstanding immediately prior to the effective time of the Merger (other than such shares (i) held by Oak Street Health as treasury stock as of immediately prior to the effective time, (ii) owned by Parent or any of its subsidiaries (including Merger Sub) as of immediately prior to the effective time, (iii) owned by stockholders who have properly exercised appraisal rights under Delaware law and (iv) subject to outstanding Oak Street Health restricted stock awards), was automatically cancelled and converted into the right to receive $39.00 per share in cash, without interest. F3 · ownership.nature: Reflects securities held directly by General Atlantic (OSH) Interholdco, L.P. (?GA Interholdco?) following the closing of the Merger. General Atlantic Partners 93, L.P., a Delaware limited partnership ("GAP 93"), General Atlantic Partners 100, L.P., a Delaware limited partnership ("GAP 100"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), and GAP Coinvestments V, LLC, a Delaware limited liability company (cont?d in FN 4). F4 · ownership.nature: (cont?d from FN 3) ("GAPCO V" and, together with GAP 93, GAP 100, GAPCO CDA, GAPCO III and GAPCO IV, the "GA Funds") are the limited partners of GA Interholdco. General Atlantic GenPar, L.P. ("GA GenPar") is the general partner of GAP 93 and GAP 100. General Atlantic (SPV) GP, LLC ("GA SPV") is the general partner of GA Interholdco. General Atlantic, L.P. ("GA LP") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. There are nine members of the management committee of GA LP (the "GA Management Committee"). Each of the members of the GA Management Committee disclaims ownership of the shares except to the extent he or she has a pecuniary interest therein. Read SEC document |
| June 01, 2021 Filed Jun 1, 2021 20:49 UTC | Oak Street Health, Inc. OSH · Entity 113906 | SaleCommon Stock, par value $0.001 per share | 7,260,689 | $60.14 | $436,657,836.46 |
DisclosureSEC source: 0000950142-21-001825 · es210156621_4-osh.xml · nonDerivative · entry 1 GENERAL ATLANTIC LLC · CIK 0001017645 · Director · 10% owner GENERAL ATLANTIC GENPAR, L.P. · CIK 0001467926 · 10% owner General Atlantic Partners 93, L.P. · CIK 0001567885 · 10% owner General Atlantic Partners 100, L.P. · CIK 0001704892 · 10% owner GAP COINVESTMENTS III, LLC · CIK 0001282203 · 10% owner GAP COINVESTMENTS IV, LLC · CIK 0001282372 · 10% owner GAP Coinvestments V, LLC · CIK 0001793941 · 10% owner GAP Coinvestments CDA, L.P. · CIK 0001356474 · 10% owner General Atlantic (SPV) GP, LLC · CIK 0001793940 · 10% owner General Atlantic (OSH) Interholdco, L.P. · CIK 0001793934 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 61,384,475 F1 · kind: The shares of Common Stock were sold by General Atlantic (OSH) Interholdco, L.P. ("GA Interholdco") pursuant to a registered public offering that closed on June 1, 2021 (the "Offering"), at a price of $60.14 (net of underwriting discount). F2 · ownership.nature: Reflects securities held directly by GA Interholdco following the closing of the Offering. General Atlantic Partners 93, L.P., a Delaware limited partnership ("GAP 93"), General Atlantic Partners 100, L.P., a Delaware limited partnership ("GAP 100"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), and GAP Coinvestments V, LLC, a Delaware limited liability company (cont'd in FN 2). F3 · ownership.nature: (cont'd from FN 1) ("GAPCO V" and, together with GAP 93, GAP 100, GAPCO CDA, GAPCO III and GAPCO IV, the "GA Funds") are the limited partners of GA Interholdco. General Atlantic GenPar, L.P. ("GA GenPar") is the general partner of GAP 93 and GAP 100. General Atlantic (SPV) GP, LLC ("GA SPV") is the general partner of GA Interholdco. General Atlantic LLC ("GA LLC") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. There are nine members of the management committee of GA LLC (the "GA Management Committee"). Each of the members of the GA Management Committee disclaims ownership of the shares except to the extent he or she has a pecuniary interest therein. Read SEC document |
| February 16, 2021 Filed Feb 16, 2021 23:05 UTC | Oak Street Health, Inc. OSH · Entity 113906 | SaleCommon Stock, par value $0.001 per share | 7,429,453 | $54.18 | $402,527,763.54 |
DisclosureSEC source: 0000950142-21-000651 · es210131854_4-osh.xml · nonDerivative · entry 1 GENERAL ATLANTIC LLC · CIK 0001017645 · Director · 10% owner GENERAL ATLANTIC GENPAR, L.P. · CIK 0001467926 · 10% owner General Atlantic Partners 93, L.P. · CIK 0001567885 · 10% owner General Atlantic Partners 100, L.P. · CIK 0001704892 · 10% owner GAP COINVESTMENTS III, LLC · CIK 0001282203 · 10% owner GAP COINVESTMENTS IV, LLC · CIK 0001282372 · 10% owner GAP Coinvestments V, LLC · CIK 0001793941 · 10% owner GAP Coinvestments CDA, L.P. · CIK 0001356474 · 10% owner General Atlantic (SPV) GP, LLC · CIK 0001793940 · 10% owner General Atlantic (OSH) Interholdco, L.P. · CIK 0001793934 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 68,645,164 F1 · kind: The shares of Common Stock were sold by General Atlantic (OSH) Interholdco, L.P. ("GA Interholdco") pursuant to a registered public offering that closed on February 16, 2021 (the "Offering"), at a price of $54.18 (net of underwriting discount). F2 · ownership.nature: Reflects securities held directly by GA Interholdco following the closing of the Offering. General Atlantic Partners 93, L.P., a Delaware limited partnership ("GAP 93"), General Atlantic Partners 100, L.P., a Delaware limited partnership ("GAP 100"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), and GAP Coinvestments V, LLC, a Delaware limited liability company (cont'd in FN 2). F3 · ownership.nature: (cont'd from FN 1) ("GAPCO V" and, together with GAP 93, GAP 100, GAPCO CDA, GAPCO III and GAPCO IV, the "GA Funds") are the limited partners of GA Interholdco. General Atlantic GenPar, L.P. ("GA GenPar") is the general partner of GAP 93 and GAP 100. General Atlantic (SPV) GP, LLC ("GA SPV") is the general partner of GA Interholdco. General Atlantic LLC ("GA LLC") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. There are nine members of the management committee of GA LLC (the "GA Management Committee"). Each of the members of the GA Management Committee disclaims ownership of the shares except to the extent he or she has a pecuniary interest therein. Read SEC document |
| August 10, 2020 Filed Aug 13, 2020 01:15 UTC | Oak Street Health, Inc. OSH · Entity 113906 | OtherCommon Stock, par value $0.001 per share | 76,074,617 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-20-002002 · es2001001_4-osh.xml · nonDerivative · entry 1 GENERAL ATLANTIC LLC · CIK 0001017645 · 10% owner GENERAL ATLANTIC GENPAR, L.P. · CIK 0001467926 · 10% owner General Atlantic Partners 93, L.P. · CIK 0001567885 · 10% owner General Atlantic Partners 100, L.P. · CIK 0001704892 · 10% owner GAP COINVESTMENTS III, LLC · CIK 0001282203 · 10% owner GAP COINVESTMENTS IV, LLC · CIK 0001282372 · 10% owner GAP Coinvestments V, LLC · CIK 0001793941 · 10% owner GAP Coinvestments CDA, L.P. · CIK 0001356474 · 10% owner General Atlantic (SPV) GP, LLC · CIK 0001793940 · 10% owner General Atlantic (OSH) Interholdco, L.P. · CIK 0001793934 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 76,074,617 F1 · kind: Reflects securities held directly by General Atlantic (OSH) Interholdco, L.P. ("GA Interholdco") as a result of certain organizational transactions effected in connection with the closing of the initial public offering of Oak Street Health Inc. General Atlantic Partners 93, L.P., a Delaware limited partnership ("GAP 93"), General Atlantic Partners 100, L.P., a Delaware limited partnership ("GAP 100"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), and GAP Coinvestments V, LLC, a Delaware limited liability company (cont'd in FN 2) F2 · kind: (cont'd from FN 1) ("GAPCO V" and, together with GAP 93, GAP 100, GAPCO CDA, GAPCO III and GAPCO IV, the "GA Funds") are the limited partners of GA Interholdco. General Atlantic GenPar, L.P. ("GA GenPar") is the general partner of GAP 93 and GAP 100. General Atlantic (SPV) GP, LLC ("GA SPV") is the general partner of GA Interholdco. General Atlantic LLC ("GA LLC") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. There are eight members of the management committee of GA LLC (the "GA Management Committee"). Each of the members of the GA Management Committee disclaims ownership of the shares except to the extent he or she has a pecuniary interest therein. F1 · ownership.nature: Reflects securities held directly by General Atlantic (OSH) Interholdco, L.P. ("GA Interholdco") as a result of certain organizational transactions effected in connection with the closing of the initial public offering of Oak Street Health Inc. General Atlantic Partners 93, L.P., a Delaware limited partnership ("GAP 93"), General Atlantic Partners 100, L.P., a Delaware limited partnership ("GAP 100"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), and GAP Coinvestments V, LLC, a Delaware limited liability company (cont'd in FN 2) F2 · ownership.nature: (cont'd from FN 1) ("GAPCO V" and, together with GAP 93, GAP 100, GAPCO CDA, GAPCO III and GAPCO IV, the "GA Funds") are the limited partners of GA Interholdco. General Atlantic GenPar, L.P. ("GA GenPar") is the general partner of GAP 93 and GAP 100. General Atlantic (SPV) GP, LLC ("GA SPV") is the general partner of GA Interholdco. General Atlantic LLC ("GA LLC") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. There are eight members of the management committee of GA LLC (the "GA Management Committee"). Each of the members of the GA Management Committee disclaims ownership of the shares except to the extent he or she has a pecuniary interest therein. Read SEC document |
| August 10, 2020 Filed Oct 22, 2020 20:03 UTC Amendment | Oak Street Health, Inc. OSH · Entity 113906 | GrantCommon Stock, par value $0.001 per share | 76,074,617 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-20-002426 · es200108102_4a-osh.xml · nonDerivative · entry 1 GENERAL ATLANTIC LLC · CIK 0001017645 · Director · 10% owner GENERAL ATLANTIC GENPAR, L.P. · CIK 0001467926 · Director · 10% owner General Atlantic Partners 93, L.P. · CIK 0001567885 · Director · 10% owner General Atlantic Partners 100, L.P. · CIK 0001704892 · Director · 10% owner GAP COINVESTMENTS III, LLC · CIK 0001282203 · Director · 10% owner GAP COINVESTMENTS IV, LLC · CIK 0001282372 · Director · 10% owner GAP Coinvestments V, LLC · CIK 0001793941 · Director · 10% owner GAP Coinvestments CDA, L.P. · CIK 0001356474 · Director · 10% owner General Atlantic (SPV) GP, LLC · CIK 0001793940 · Director · 10% owner General Atlantic (OSH) Interholdco, L.P. · CIK 0001793934 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 76,074,617 F1 · kind: Reflects securities held directly by General Atlantic (OSH) Interholdco, L.P. ("GA Interholdco") as a result of certain organizational transactions effected in connection with the closing of the initial public offering of Oak Street Health Inc. General Atlantic Partners 93, L.P., a Delaware limited partnership ("GAP 93"), General Atlantic Partners 100, L.P., a Delaware limited partnership ("GAP 100"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), and GAP Coinvestments V, LLC, a Delaware limited liability company (cont'd in FN 2) F2 · kind: (cont'd from FN 1) ("GAPCO V" and, together with GAP 93, GAP 100, GAPCO CDA, GAPCO III and GAPCO IV, the "GA Funds") are the limited partners of GA Interholdco. General Atlantic GenPar, L.P. ("GA GenPar") is the general partner of GAP 93 and GAP 100. General Atlantic (SPV) GP, LLC ("GA SPV") is the general partner of GA Interholdco. General Atlantic LLC ("GA LLC") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. There are eight members of the management committee of GA LLC (the "GA Management Committee"). Each of the members of the GA Management Committee disclaims ownership of the shares except to the extent he or she has a pecuniary interest therein. F3 · kind: This Form 4 is not being filed to report any new transactions. The reporting persons' initial filing correctly reported the transactions described on Table I thereto, but this filing amends the transaction code. F1 · ownership.nature: Reflects securities held directly by General Atlantic (OSH) Interholdco, L.P. ("GA Interholdco") as a result of certain organizational transactions effected in connection with the closing of the initial public offering of Oak Street Health Inc. General Atlantic Partners 93, L.P., a Delaware limited partnership ("GAP 93"), General Atlantic Partners 100, L.P., a Delaware limited partnership ("GAP 100"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), and GAP Coinvestments V, LLC, a Delaware limited liability company (cont'd in FN 2) F2 · ownership.nature: (cont'd from FN 1) ("GAPCO V" and, together with GAP 93, GAP 100, GAPCO CDA, GAPCO III and GAPCO IV, the "GA Funds") are the limited partners of GA Interholdco. General Atlantic GenPar, L.P. ("GA GenPar") is the general partner of GAP 93 and GAP 100. General Atlantic (SPV) GP, LLC ("GA SPV") is the general partner of GA Interholdco. General Atlantic LLC ("GA LLC") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. There are eight members of the management committee of GA LLC (the "GA Management Committee"). Each of the members of the GA Management Committee disclaims ownership of the shares except to the extent he or she has a pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.